☰

Ashley M. James, Ph.D. - Publications

Affiliations: 
2012 Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cell Biology, Immunology
Tree Info Grants Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Pazina T, James AM, Colby KB, Yang Y, Gale A, Jhatakia A, Kearney AY, Graziano RF, Bezman NA, Robbins MD, Cohen AD, Campbell KS. Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma. Cancer Immunology Research. PMID 31431433 DOI: 10.1158/2326-6066.Cir-18-0579  0.498
2018 Pazina T, James AM, Jhatakia A, Graziano RF, Bezman NA, Robbins MD, Cohen AD, Campbell KS. Elotuzumab Promotes Self-Engagement of Signaling Lymphocytic Activation Molecule Family Member 7 (SLAMF7) Between Natural Killer (NK) and Multiple Myeloma (MM) Cells to Enhance Cytotoxicity Clinical Lymphoma Myeloma and Leukemia. 18: S253-S254. DOI: 10.1016/j.clml.2018.07.156  0.324
2017 Pazina T, James AM, MacFarlane AW, Bezman NA, Henning KA, Bee C, Graziano RF, Robbins MD, Cohen AD, Campbell KS. The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms. Oncoimmunology. 6: e1339853. PMID 28932638 DOI: 10.1080/2162402X.2017.1339853  0.456
2017 Pazina T, James AM, MacFarlane AW, Bezman NA, Graziano RF, Robbins MD, Cohen AD, Campbell KS. Abstract 2998: Elotuzumab can costimulate NK cell responses by engaging SLAMF7 Cancer Research. 77: 2998-2998. DOI: 10.1158/1538-7445.Am2017-2998  0.448
2014 Purdy AK, Alvarez Arias DA, Oshinsky J, James AM, Serebriiskii I, Campbell KS. The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells. Journal of Immunology (Baltimore, Md. : 1950). 193: 4675-83. PMID 25238755 DOI: 10.4049/Jimmunol.1303406  0.48
2014 Mace EM, Dongre P, Hsu HT, Sinha P, James AM, Mann SS, Forbes LR, Watkin LB, Orange JS. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunology and Cell Biology. 92: 245-55. PMID 24445602 DOI: 10.1038/Icb.2013.96  0.611
2014 Pazina T, James AM, Cohen AD, Campbell KS. Enhancing the Cytotoxicity of NK Cells Toward Multiple Myeloma Using an Antibody Specific to SLAMF7 Blood. 124: 2092-2092. DOI: 10.1182/Blood.V124.21.2092.2092  0.508
2013 Tuli A, Thiery J, James AM, Michelet X, Sharma M, Garg S, Sanborn KB, Orange JS, Lieberman J, Brenner MB. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity. Molecular Biology of the Cell. 24: 3721-35. PMID 24088571 DOI: 10.1091/Mbc.E13-05-0259  0.535
2013 James AM, Hsu HT, Dongre P, Uzel G, Mace EM, Banerjee PP, Orange JS. Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling. Blood. 121: 2627-37. PMID 23380740 DOI: 10.1182/Blood-2012-06-437012  0.577
2006 Baptiste TA, James A, Saria M, Ochieng J. Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. Experimental Cell Research. 313: 652-64. PMID 17184769 DOI: 10.1016/j.yexcr.2006.11.005  0.31
1956 Ambrose EJ, James AM, Lowick JHB. Differences between the electrical charge carried by normal and homologous tumour cells Nature. 177: 576-577. PMID 13321908 DOI: 10.1038/177576a0  0.326
1949 UNGAR J, JAMES AM. Factors affecting the agglutinability of red cells by Haemophilus pertussis Journal of General Microbiology. 3: xxv. PMID 18225058  0.306
Show low-probability matches.